Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

What is the optimal follow-up strategy for patients with papillary thyroid microcarcinoma?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 426–427 (2006)Cite this article

boxed-textTorlontano M et al. (2006) Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy. J Clin Endocrinol Metab 91: 60–63

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Mazzaferri EL et al. (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low risk patients with papillary carcinoma. J Clin Endocrinol Metab 88: 1433–1441

    Article  CAS  Google Scholar 

  2. Schlumberger M et al. (2004) Follow-up of low risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150: 105–112

    Article  CAS  Google Scholar 

  3. Pacini F et al. (2002) Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. J Clin Endocrinol Metab 87: 1499–1501

    Article  CAS  Google Scholar 

  4. Pacini F et al. (2003) Recombinant human thyrotropin-stimulated serum thyroglobulin in combination with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88: 3668–3673

    Article  CAS  Google Scholar 

  5. Torlontano M et al. (2004) Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89: 3402–3407

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Head of the Department of Medical Endocrinology, National University Hospital, Copenhagen, Denmark

    Ulla Feldt-Rasmussen

Authors
  1. Ulla Feldt-Rasmussen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulla Feldt-Rasmussen.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldt-Rasmussen, U. What is the optimal follow-up strategy for patients with papillary thyroid microcarcinoma?. Nat Rev Endocrinol 2, 426–427 (2006). https://doi.org/10.1038/ncpendmet0227

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0227

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing